Cambridge Investment Research Advisors »

Trisalus Life Sciences shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $152k 16k 9.77
2023-12-31 $131k 16k 8.42

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Trisalus Life Sciences

Vanguard Group
Geode Capital Management
HC Advisors
Connecticut Wealth Management
BlackRock
Wetherby Asset Management
Northern Trust
Anson Capital
Cambridge Investment Research Advisors
Jpmorgan Chase & Co
Tyche Wealth Partners
Qube Research & Technologies
Wells Fargo & Company
Hoertkorn Richard Charles
GPS Wealth Strategies Group

View all funds holding Trisalus Life Sciences